Thursday, January 19, 2023 2:43:05 AM
FYI, no updates, no news, no study information, no FDA updates or approval, no SEC updates to sell their unregistered securities (they must be registered to sell or dilute and the SEC refused to review them), no patent update, no new insider buying/selling, no new institutional additions/departures/changes, and no update on their financial status (which is coming).
The SEC denied their acceleration requests, and in my opinion, they are a carbon copy of CytoDyn.
adva-27a may come back to haunt them as it was erroneously valued at 1 billion dollars.
SBFM-PL-4 appears to be abandoned and the FDA won't approve it and neither will the patent office (this got CytoDyn into trouble with the SEC for their covid claims).
adva-27a, their flagship, is nearing expiration and it has been denied approval by the FDA.
The recent acquisition of Nora is going to be a headache for SBFM if they run out of cash (they can't secure loans, dilute, or fundraise according to their November filing, which is related to the SEC).
Nora was a nothing company until March of 2022, when they bought a pharmaceutical plant. Net profit went from 150K to 350K. Still not much of a company. Revenue almost 11M, with 350K in net profit?
Companies combined, the net profit of SBFM is not even $1m. They have more than 3 employees now, they have an alleged pharmaceutical plant, and they will need operation cash to cover pay roll, HR, maintenance, working equipment, and the ability to buy supplies to manufacture generics, fish oil, and whey protein.
The company itself has nothing much to offer, they don't have any marketable patents or their own FDA approved pharmaceuticals. They can't even get to a phase 1 trial.
SBFM-PL-4 was not approved for a patent, only an *international* application number filed in May of 2021, 1 year after they stated they applied for FDA & patent acceleration back in May of 2020. This could be a problem for them as well as amended filings that generated a material impact, the lack of filing an 8-K for their "silent" so-called LNP partner, and so many other things.
There is not much proof that the plant is even operational, at what capacity, and what the last quarter sales (revenue & profit) are for Nora. And SBFM.
What I mentioned before, this company could pop because the O/S & float is around 22M. Half the insiders own nearly 50% of that 22M, so the actual number is less than 11M (float).
That's why I mentioned it could pop like Mt St Helens on no news. The bad news is very bad. It could crash just as quickly as it pops, or much much worse.
Recent SBFM News
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/20/2024 08:05:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 08:05:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/16/2024 09:00:24 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 08:05:09 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 07/11/2024 08:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:05:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 03/05/2024 09:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:03:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:28:39 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/21/2024 01:24:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 04:39:32 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:53:03 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/14/2024 04:18:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/13/2024 05:15:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:04:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:17:56 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:17:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 05:38:24 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2024 01:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:59:51 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM